Sample sizes in COVID-19-related research.
作者信息
Lee Paul H
机构信息
School of Nursing, Hong Kong Polytechnic University, Hung Hom, Hong Kong.
出版信息
CMAJ. 2020 Apr 27;192(17):E461. doi: 10.1503/cmaj.75308.
Abstract
摘要
相似文献
1
Sample sizes in COVID-19-related research.新冠疫情相关研究中的样本量。
CMAJ. 2020 Apr 27;192(17):E461. doi: 10.1503/cmaj.75308.
2
The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed.在PubMed上索引的关于COVID-19患者的临床试验中报告的样本量计算质量。
Eur J Intern Med. 2020 Jul;77:139-140. doi: 10.1016/j.ejim.2020.04.057. Epub 2020 Apr 30.
3
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.新冠病毒肺炎患者女性生殖道中严重急性呼吸综合征冠状病毒2的评估：一项前瞻性研究。
J Biol Regul Homeost Agents. 2020;34(5):1885-1888. doi: 10.23812/20-352-L.
4
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
5
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
6
Research Response to SARS-CoV-2/COVID-19.对严重急性呼吸综合征冠状病毒2/2019冠状病毒病的研究应对措施
Mayo Clin Proc. 2020 Sep;95(9S):S52-S55. doi: 10.1016/j.mayocp.2020.06.048. Epub 2020 Jul 7.
7
Treatments for COVID-19: emerging drugs against the coronavirus.新冠病毒病的治疗方法：对抗冠状病毒的新型药物
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.9982.
8
[COVID-19-never waste a crisis?!].[新冠疫情——切莫浪费一场危机？！]
Radiologe. 2020 Oct;60(10):891-892. doi: 10.1007/s00117-020-00750-x.
9
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
10
[Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].[2019新型冠状病毒（严重急性呼吸综合征冠状病毒2）的检测方法]
Zhongguo Yi Liao Qi Xie Za Zhi. 2020 Apr 8;44(4):359-362. doi: 10.3969/j.issn.1671-7104.2020.04.017.
引用本文的文献
1
Hematological- and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases.用于区分新型冠状病毒肺炎患者与其他病毒性呼吸道疾病患者的血液学和免疫学相关生物标志物
J Clin Med. 2022 Jun 21;11(13):3578. doi: 10.3390/jcm11133578.
本文引用的文献
1
Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.生成随机试验证据以优化新冠疫情中的治疗。
CMAJ. 2020 Apr 14;192(15):E405-E407. doi: 10.1503/cmaj.200438. Epub 2020 Mar 26.
2
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
3
High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial.高流量鼻导管给氧辅助纤维支气管镜引导气管插管用于新型冠状病毒肺炎危重症患者：一项前瞻性随机对照试验
Br J Anaesth. 2020 Jul;125(1):e166-e168. doi: 10.1016/j.bja.2020.02.020. Epub 2020 Mar 20.
4
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
5
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial.糖皮质激素治疗重症 2019 冠状病毒病患者的有效性：一项随机对照试验方案。
Chin Med J (Engl). 2020 May 5;133(9):1080-1086. doi: 10.1097/CM9.0000000000000791.
6
A simple approximation for calculating sample sizes for comparing independent proportions.一种用于计算比较独立比例时样本量的简单近似方法。
Biometrics. 1980 Jun;36(2):343-6.
Zotero 插件